---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-152868"
form_type: "8-K"
ticker: "SANA"
cik: "0001770121"
company_name: "Sana Biotechnology, Inc."
filed_at: "2026-04-13T23:59:59+00:00"
generated_at: "2026-05-15T06:35:58.695736+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sana Biotechnology sells $25M in stock to Mayo Clinic with option for additional $25M

## Summary
- Issued 7,507,507 shares at $3.33 each to Mayo Clinic for ~$25M gross proceeds; closing expected April 15, 2026.
- Mayo Clinic can purchase another 7,507,507 shares at same price by Aug 31, 2026, for ~$25M additional.
- Net proceeds to fund development of SC451 and genetically modified stem-cell derived islet cell products under new license agreement.
- Mayo Clinic subject to 6-month lock-up from initial closing (or 3 months from second closing if elected).
- Cash of $138.4M (Dec 31, 2025) plus ~$24.9M net from initial closing expected to fund operations into 2027.

## SEC filing metadata
- accession: 0001193125-26-152868
- form_type: 8-K
- ticker: SANA
- cik: 0001770121
- company_name: Sana Biotechnology, Inc.
- filed_at: 2026-04-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1770121/000119312526152868/0001193125-26-152868-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1770121/000119312526152868/sana-20260410.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-152868
- JSON: https://secwatch.observer/filing/0001193125-26-152868.json
- Plain text: https://secwatch.observer/filing/0001193125-26-152868.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.